Literature DB >> 16153179

The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses.

Colin R Parrish1, Yoshihiro Kawaoka.   

Abstract

Transfer of viruses between hosts to create a new self-sustaining epidemic is rare; however, those new viruses can cause severe outbreaks. Examples of such viruses include three pandemic human influenza A viruses and canine parvovirus in dogs. In each case one virus made the original transfer and spread worldwide, and then further adaptation resulted in the emergence of variants worldwide. For the influenza viruses several changes were required for growth and spread between humans, and the emergence of human H2N2 and H3N2 strains in 1957 and 1968 involved the acquisition of three or two new genomic segments, respectively. Adaptation to humans involved several viral genes including the hemagglutinin, the neuraminidase, and the replication proteins. The canine adaptation of the parvoviruses involved capsid protein changes altering the recognition of the host transferrin receptors, allowing canine transferrin receptor binding and its use as a receptor for cell infection.

Entities:  

Mesh:

Year:  2005        PMID: 16153179     DOI: 10.1146/annurev.micro.59.030804.121059

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  118 in total

1.  Role of multiple hosts in the cross-species transmission and emergence of a pandemic parvovirus.

Authors:  Andrew B Allison; Carole E Harbison; Israel Pagan; Karla M Stucker; Jason T Kaelber; Justin D Brown; Mark G Ruder; M Kevin Keel; Edward J Dubovi; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003.

Authors:  U B Aamir; Ulrich Wernery; N Ilyushina; R G Webster
Journal:  Virology       Date:  2006-12-08       Impact factor: 3.616

4.  The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.

Authors:  Netanel Tzarum; Robert P de Vries; Wenjie Peng; Andrew J Thompson; Kim M Bouwman; Ryan McBride; Wenli Yu; Xueyong Zhu; Monique H Verheije; James C Paulson; Ian A Wilson
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

5.  Comparative analysis reveals frequent recombination in the parvoviruses.

Authors:  Laura A Shackelton; Karin Hoelzer; Colin R Parrish; Edward C Holmes
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

6.  Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus.

Authors:  Netanel Tzarum; Robert P de Vries; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

7.  Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.

Authors:  Rui Xu; Ryan McBride; James C Paulson; Christopher F Basler; Ian A Wilson
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

9.  Frequent cross-species transmission of parvoviruses among diverse carnivore hosts.

Authors:  Andrew B Allison; Dennis J Kohler; Karen A Fox; Justin D Brown; Richard W Gerhold; Valerie I Shearn-Bochsler; Edward J Dubovi; Colin R Parrish; Edward C Holmes
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Transferrin receptor binds virus capsid with dynamic motion.

Authors:  Hyunwook Lee; Heather M Callaway; Javier O Cifuente; Carol M Bator; Colin R Parrish; Susan L Hafenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.